-
High Prevalence of Multidrug-Resistant Organism Colonization in 28 Nursing Homes: An "Iceberg Effect". J Am Med Dir Assoc. 2020 12; 21(12):1937-1943.e2.
McKinnell JA, Miller LG, Singh RD, Gussin G, Kleinman K, Mendez J, Laurner B, Catuna TD, Heim L, Saavedra R, Felix J, Torres C, Chang J, Estevez M, Mendez J, Tchakalian G, Bloomfield L, Ceja S, Franco R, Miner A, Hurtado A, Hean R, Varasteh A, Robinson PA, Park S, Tam S, Tjoa T, He J, Agrawal S, Yamaguchi S, Custodio H, Nguyen J, Bittencourt CE, Evans KD, Mor V, McConeghy K, Weinstein RA, Hayden MK, Stone ND, Steinberg K, Beecham N, Montgomery J, DeAnn W, Peterson EM, Huang SS. PMID: 32553489.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCells
-
Non-O blood group thrombotic thrombocytopenic purpura patients take longer to recover as measured by number of therapeutic plasma exchanges needed for platelet recovery. Thromb Res. 2020 01; 185:78-84.
Behtaj M, Zhu ML, Bittencourt CE, Ha JP, Maitta RW. PMID: 31778944.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCells
-
The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California. Clin Infect Dis. 2019 10 15; 69(9):1566-1573.
McKinnell JA, Singh RD, Miller LG, Kleinman K, Gussin G, He J, Saavedra R, Dutciuc TD, Estevez M, Chang J, Heim L, Yamaguchi S, Custodio H, Gohil SK, Park S, Tam S, Robinson PA, Tjoa T, Nguyen J, Evans KD, Bittencourt CE, Lee BY, Mueller LE, Bartsch SM, Jernigan JA, Slayton RB, Stone ND, Zahn M, Mor V, McConeghy K, Baier RR, Janssen L, O'Donnell K, Weinstein RA, Hayden MK, Coady MH, Bhattarai M, Peterson EM, Huang SS. PMID: 30753383.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCellsPHPublic Health
-
Correction for Kraft et al., "A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults". Clin Microbiol Rev. 2019 Sep 18; 32(4).
Kraft CS, Parrott JS, Cornish NE, Rubinstein ML, Weissfeld AS, McNult P, Nachamkin I, Humphries RM, Kirn TJ, Dien Bard J, Lutgring JD, Gullett JC, Bittencourt CE, Benson S, Bobenchik AM, Sautter RL, Baselski V, Atlas MC, Marlowe EM, Miller NS, Fischer M, Richter SS, Gilligan P, Snyder JW. PMID: 31462404.
View in:
PubMed Mentions: Fields:
-
Brucellosis Presenting as Cholecystitis: A Case Report and Literature Review. Open Forum Infect Dis. 2019 Oct; 6(10):ofz334.
Speiser L, Hsieh L, Huang SS, Bittencourt C, Forthal D. PMID: 31660329.
View in:
PubMed Mentions:
-
A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults. Clin Microbiol Rev. 2019 06 19; 32(3).
Kraft CS, Parrott JS, Cornish NE, Rubinstein ML, Weissfeld AS, McNult P, Nachamkin I, Humphries RM, Kirn TJ, Dien Bard J, Lutgring JD, Gullett JC, Bittencourt CE, Benson S, Bobenchik AM, Sautter RL, Baselski V, Atlas MC, Marlowe EM, Miller NS, Fischer M, Richter SS, Gilligan P, Snyder JW. PMID: 31142497.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCells
-
Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers. J Clin Microbiol. 2018 04; 56(4).
Lutgring JD, Bittencourt C, McElvania TeKippe E, Cavuoti D, Hollaway R, Burd EM. PMID: 29386262.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansCells
-
Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing. Infect Control Hosp Epidemiol. 2018 05; 39(5):625-627.
Quan KA, Yim J, Merrill D, Khusbu U, Madey K, Dickey L, Dangodara AA, Rudkin SE, O'Brien M, Thompson D, Parekh N, Albers CG, Wilson WC, Thrupp L, Bittencourt CE, Huang SS, Gohil SK. PMID: 29552992.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCells
-
Correction: Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome. PLoS One. 2015; 10(6):e0131384.
Bittencourt CE, Ha JP, Maitta RW. PMID: 26098743.
View in:
PubMed Mentions: Fields:
-
Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. PLoS One. 2015; 10(5):e0127744.
Bittencourt CE, Ha JP, Maitta RW. PMID: 26000799.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans